Candriam SCA’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7M | Sell |
195,115
-47,646
| -20% | -$8.22M | 0.19% | 107 |
|
|
2025
Q1 | $37.8M | Sell |
242,761
-37,393
| -13% | -$5.83M | 0.24% | 95 |
|
|
2024
Q4 | $38.6M | Sell |
280,154
-2,177
| -0.8% | -$300K | 0.22% | 92 |
|
|
2024
Q3 | $42.2M | Buy |
282,331
+86,984
| +45% | +$13M | 0.24% | 87 |
|
|
2024
Q2 | $26.6M | Buy |
195,347
+95,972
| +97% | +$13.1M | 0.16% | 130 |
|
|
2024
Q1 | $15M | Hold |
99,375
| – | – | 0.1% | 204 |
|
|
2023
Q4 | $12.5M | Sell |
99,375
-40,000
| -29% | -$5.04M | 0.09% | 225 |
|
|
2023
Q3 | $13.1M | Sell |
139,375
-9,000
| -6% | -$843K | 0.09% | 197 |
|
|
2023
Q2 | $13.2M | Sell |
148,375
-102,000
| -41% | -$9.1M | 0.1% | 212 |
|
|
2023
Q1 | $24.7M | Buy |
250,375
+60,000
| +32% | +$5.92M | 0.17% | 139 |
|
|
2022
Q4 | $23.2M | Sell |
190,375
-16,000
| -8% | -$1.95M | 0.16% | 152 |
|
|
2022
Q3 | $21.3M | Sell |
206,375
-14,376
| -7% | -$1.48M | 0.15% | 155 |
|
|
2022
Q2 | $20.5M | Buy |
220,751
+56,433
| +34% | +$5.25M | 0.17% | 137 |
|
|
2022
Q1 | $19.3M | Sell |
164,318
-74,104
| -31% | -$8.7M | 0.13% | 169 |
|
|
2021
Q4 | $32.1M | Sell |
238,422
-11,977
| -5% | -$1.61M | 0.2% | 126 |
|
|
2021
Q3 | $39.9M | Sell |
250,399
-32,581
| -12% | -$5.19M | 0.27% | 88 |
|
|
2021
Q2 | $37.2M | Buy |
282,980
+42,309
| +18% | +$5.57M | 0.25% | 93 |
|
|
2021
Q1 | $38.6M | Hold |
240,671
| – | – | 0.32% | 77 |
|
|
2020
Q4 | $40.1M | Sell |
240,671
-28,408
| -11% | -$4.74M | 0.32% | 77 |
|
|
2020
Q3 | $41.5M | Buy |
269,079
+79,000
| +42% | +$12.2M | 0.39% | 53 |
|
|
2020
Q2 | $28.1M | Buy |
190,079
+78,079
| +70% | +$11.5M | 0.3% | 85 |
|
|
2020
Q1 | $15.2M | Hold |
112,000
| – | – | 0.17% | 145 |
|
|
2019
Q4 | $15.6M | Buy |
112,000
+18,000
| +19% | +$2.5M | 0.17% | 145 |
|
|
2019
Q3 | $9.05M | Buy |
+94,000
| New | +$9.05M | 0.12% | 202 |
|